Cohort PLC
LSE:CHRT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cohort PLC
LSE:CHRT
|
UK |
|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
US |
|
BiVictriX Therapeutics PLC
LSE:BVX
|
UK |
Wall Street
Price Targets
CHRT Price Targets Summary
Cohort PLC
According to Wall Street analysts, the average 1-year price target for
CHRT
is 1 637.1 GBX
with a low forecast of 1 444.3 GBX and a high forecast of 1 837.5 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CHRT's stock price target?
Price Target
1 637.1
GBX
According to Wall Street analysts, the average 1-year price target for
CHRT
is 1 637.1 GBX
with a low forecast of 1 444.3 GBX and a high forecast of 1 837.5 GBX.
What is Cohort PLC's Revenue forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Cohort PLC's revenue is
10%.
The projected
CAGR
for the next 3 years is
8%.
What is Cohort PLC's Operating Income forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Cohort PLC's operating income is
15%.
The projected
CAGR
for the next 3 years is
22%.
What is Cohort PLC's Net Income forecast?
Projected CAGR
23%
For the last 13 years the
compound annual growth rate for
Cohort PLC's net income is
12%.
The projected
CAGR
for the next 3 years is
23%.
